Defending neurodiversity in the face of Trump’s Tylenol-autism claims
This episode discusses the Trump administration's claims linking Tylenol usage to autism. The conversation explores professional lessons for health brands and medical marketers, as well as personal insights from those living with autism or caring for those who do.